1766 vice president clinical development jobs found

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com Job Function: Discovery & Pre-Clinical/Clinical Development Job Sub Function: Clinical Development & Research - MD Job Category: People Leader All Job Posting Locations: Spring House, Pennsylvania, United States of America Job Description: Johnson & Johnson is currently seeking a Vice President, Clinical Development - Rheumatology, Rare and Maternal Fetal Immunology (MFI) to join our Late Stage Clinical Development team located in...

Company Overview At Aditum Bio our mission is to provide access to medicines to patients in need. Co-founded by industry veterans Joe Jimenez, former CEO of Novartis and Mark Fishman, former President of the Novartis Institutes for Biomedical Research, the firm in-licenses promising therapies and advances them into Phase 1 and Phase 2 clinical studies to enable proof of concept. The firm focuses on the translational phase of medicine to generate data that can support full clinical development, and eventual market launch, to reach patients in need. Position Summary Aditum Bio is seeking a Vice President, Clinical Development with experience in Phase II development who will own the overall design and execution of designated Portfolio Companies clinical trials. This includes the translation of preclinical data into clinical trial design and execution, clinical trial strategy and protocols. The ideal candidate has a demonstrated command of early clinical phase drug development...

Company Description Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States focused on bringing transformative medicines for oncology, autoimmune disorders, infectious diseases, and neurological disorders to patients in China and around the world. Our goal is to leverage our competencies and resources to positively impact human health worldwide. Founded in 2014, our experienced team has secured partnerships with leading global biopharmaceutical companies, generating a broad and late-stage pipeline of innovative drug candidates. Based on our proven track record of success, Zai Lab has earned the reputation as a trusted partner of choice for global biopharmaceutical companies seeking to not only access the Chinese market but also find a long-term strategic partner for global clinical development. Our unique business model builds on our in-licensed assets and innovative partnerships...

Who We Are: Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click's treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click's platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology,...

POSITION SUMMARY: Reporting to the Chief Medical Officer (CMO), the Clinical Development, Vice President manages the clinical development of drug candidates, creating integrated clinical development strategies and plans reflecting specific needs for registration and commercial success. The Vice President, Clinical Development will have a deep understanding of all phases of pharmaceutical drug product development, regulatory experience and will collaborate efficiently with other key stakeholders (Biometrics, Research, Medical Affairs, Regulatory Affairs, etc), providing strategic and operational leadership to the clinical project teams. Salary Range: Premium $318,240 - $374,000 National $286,500 - 337,000 ESSENTIAL DUTIES AND RESPONSIBILITIES : Lead the development and execution of the clinical program strategy, including formulation of clinical development plans Design, plan, execute, interpret and communicate clinical trials/research and results, according to...

Who We Are: Xenon Pharmaceuticals (NASDAQ:XENE) is a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team. What We Do: We are advancing an exciting product pipeline to address indications with high unmet medical need, including epilepsy and depression. Our flagship azetukalner program represents the most advanced potassium channel modulator in clinical development for multiple indications. Building upon the positive results and compelling data from our Phase 2b "X-TOLE" study in adult patients with focal epilepsy, our Phase 3 epilepsy program includes multiple clinical trials evaluating azetukalner in patients with focal onset seizures and primary generalized tonic-clonic seizures. In...

Who we are: Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients' lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston's top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn. How we work: PIONEER : We are courageous, resilient and rigorous in our mission to improve patients' lives...

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are passionate in our singular pursuit of discovering, developing and delivering innovative targeted therapies for patients living with RAS-addicted cancer. At Revolution Medicines, we believe in challenging the status quo to find new therapeutic approaches to some of the toughest cancers. With our first wave of investigational RAS(ON) Inhibitors, we are pioneering a new way of targeting the RAS cancer...

Surrozen is a biotechnology company pioneering targeted therapeutics that selectively activate the Wnt Pathway for tissue repair and regeneration. Surrozen is focusing its Wnt biology expertise and Wnt signal modulation antibody technologies on its ophthalmology programs including development of new treatment options for retinopathies. The Company recently completed a private placement consisting of two tranches in aggregate up to $175 million in gross proceeds to fund multiple ophthalmology programs through initial Phase 1 safety, tolerability and efficacy studies. Phase 1 studies are expected to commence in 2026. Modulation of Wnt signaling has the potential to be relevant in a broad range of highly prevalent eye diseases including "wet" and "dry" Age Related Macular Degeneration (AMD), diabetic retinopathy, Fuchs' endothelial corneal dystrophy (FECD), and non-infectious uveitis as well as certain rare eye diseases like retinitis pigmentosa, Stargardt's and Familial Exudative...

Every child deserves the brightest future and Centria Autism Services is on a mission to help children with Autism Spectrum Disorder (ASD) have the best developmental experience possible while acquiring the skills to succeed in the world on their own terms. Too many children with ASD are untreated or undertreated and Centria is committed to reaching every child in need and their families with interventions based on the principles of Applied Behavior Analysis that meet - and exceed -- best practices. Our Optimal Outcomes Model(TM) looks at the whole-child, engages families in aspirational treatment planning and leverages team-based care to allow BCBA's to focus on clinical issues and support Centria's dedication to quality, family satisfaction and developmental outcomes. Founded in 2009, Centria now operates in 13 states and is working hard to develop approaches to sustain quality while reaching tens of thousands of children across the country; we use data-driven analytics and...

About Every Cure - Every Cure is an AI-driven nonprofit, biotech organization on a mission to save and improve lives by repurposing existing medicines for diseases with significant unmet need. Our vision is a world where no patients suffer when there's a treatment sitting at their local pharmacy that could be repurposed to treat them. We are filling a gap left by the current biomedical system, which doesn't pursue new uses for cheap, old drugs. Through artificial intelligence technologies, collaboration with healthcare professionals, and patient advocacy, Every Cure is dedicated to unlocking the full potential of existing medicines to treat every disease and every patient we possibly can. Inspired by Every Cure's co-founders' work repurposing drugs for Castleman disease and other rare diseases, Every Cure is advancing repurposed treatments for neglected diseases and has been featured in New York Times, USA Today, and Good Morning America. Led by a talented leadership team and an...

Job Description: We are seeking a highly motivated and qualified individual to join ADARx Pharmaceuticals as an Associate Vice President, Clinical Development (MD) to serve as a key clinical leader responsible for driving the strategy, design, and execution of late-stage clinical programs across one or more of ADARx's therapeutic areas. The AVP will provide strong scientific and medical leadership for clinical trials, collaborating cross-functionally with R&D, regulatory, biometrics, and commercial teams. This individual will also represent ADARx externally to regulatory agencies, key opinion leaders, and partners. Essential Responsibilities: Lead and provide strategic oversight for the planning and execution of late-stage clinical trials (Phases 1, 2, and Phase 3) for one or more programs across multiple therapeutic areas. Serve as the medical monitor for clinical studies, ensuring safety data review, protocol compliance, and high-quality data output. Author and...

Company Overview: Strand Therapeutics is a clinical stage biotechnology company utilizing synthetic biology to genetically program mRNA to deliver truly revolutionary immunotherapies to patients. Building on the idea of creating smart therapies based on Boolean logic circuits, Strand was started by biological engineers working together at MIT who were seeking to apply the concept of the emerging field of mRNA therapeutics. Strand's technology is therapeutic-area and mRNA modality agnostic where therapeutic proteins are encoded onto modified, self-replicating, or circular mRNA backbones which in turn are programmed with cell-specific sensors and circuits. Today, Strand has established three platforms with one clinical stage asset and several programs in preclinical development as well as early discovery. Our lead program, STX-001, is currently being evaluated in a phase 1 clinical trial for solid tumors. Our corporate headquarters is located in the Fenway district of Boston,...

COMPANY BACKGROUND Precision for Medicine is the first biomarker-driven clinical research and development services organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively. Precision applies a transformational approach to clinical research that integrates clinical trial design and execution with deep scientific knowledge, laboratory expertise, data sciences and advanced manufacturing solutions. This convergence is driving faster clinical development and approval. Precision for Medicine is part of Precision Medicine Group, with 3,400 people in 40 locations globally, across North America, Europe and Asia-Pacific. In 2020, Precision Medicine Group completed a major investment and recapitalization led by funds managed by Blackstone, with significant participation from Precision's co-founders, Ethan Leder and Mark Clein, as well as current shareholders Berkshire Partners, TPG Growth, Oak HC/FT, and...

COMPANY BACKGROUND Precision for Medicine is the first biomarker-driven clinical research and development services organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively. Precision applies a transformational approach to clinical research that integrates clinical trial design and execution with deep scientific knowledge, laboratory expertise, data sciences and advanced manufacturing solutions. This convergence is driving faster clinical development and approval. Precision for Medicine is part of Precision Medicine Group, with 3,400 people in 40 locations globally, across North America, Europe and Asia-Pacific. In 2020, Precision Medicine Group completed a major investment and recapitalization led by funds managed by Blackstone, with significant participation from Precision's co-founders, Ethan Leder and Mark Clein, as well as current shareholders Berkshire Partners, TPG Growth, Oak HC/FT, and...

Job Description Summary Job Description Opportunity: Vice President, Strategy and Business Development, Urology & Critical Care (UCC) We are the makers of possible BD is one of the largest global medical technology companies in the world. Advancing the world of health™ is our Purpose, and it's no small feat. It takes the imagination and passion of all of us-from design and engineering to the manufacturing and marketing of our billions of MedTech products per year-to look at the impossible and find transformative solutions that turn dreams into possibilities. We believe that the human element, across our global teams, is what allows us to continually evolve. Join us and discover an environment in which you'll be supported to learn, grow and become your best self. Become a maker of possible with us. BD at a glance BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health...

Overview *Salary Range:$125,000-$145,000* Salary is dependent on licensure The Vice President of Developmental and Brain Injury Clinical Services will oversee and coordinate all clinical services and supports across Developmental and Brain Injury programs. This person will work to further the organization's vision to develop, promote and maintain high quality integrated clinical services across service lines. They will oversee a department of licensed clinicians assuring all clinical regulatory requirements are met. Responsibilities will include supervision of clinical staff and consultants and overseeing all clinical aspects of clinical assessment, service planning, interventions and clinical training. As a senior leader, the Vice President of DS/BI Clinical Services will work with the Senior Leadership Team to ensure quality service provision in day and residential services. This includes the promotion and implementation of Positive Behavioral Supports systems throughout the...

Who We Are PathAI is on a mission to improve patient outcomes with AI-powered pathology. We are transforming traditional pathology methods into powerful, new technologies. These innovations in pathology can help accelerate drug development, improve confidence in the accuracy of diagnosis, and get life-saving therapies to patients more quickly. At PathAI, you'll work with a diverse and talented team of people, who are dedicated to solving complex problems and making a huge impact. Where You Fit This SVP level role consists of three primary areas of responsibility: CAP/CLIA Lab Medical Director, Leadership of Pathology Function, Clinical Development Services, and Support of Business Development. These areas of responsibility are described in greater detail below. What You'll Do CAP/CLIA Lab Medical Director Develop and maintain an effective working relationship with laboratory management. Actively participate in lab operations meetings. Assist in setting goals,...

Job Details Level Senior Job Location DSS Juno Beach - Juno Beach, FL Remote Type Hybrid Position Type Full Time Education Level 4 Year Degree Travel Percentage Up to 25% Job Shift Day Description Why Join Us? AtJuno Health, we're not just building software-we're transforming healthcare. As a division ofDSS, Inc., we bring together over575 years of clinical experienceand30+ years of software innovationto deliver ONC-certified EHR solutions that empower providers and improve patient outcomes. OVERVIEW The Vice President of Product Operations is a senior executive responsible for overseeing the day-to-day operations of the company's software products. This role ensures operational sustainability, cost-effectiveness, and alignment with broader business objectives. The leader manages cross-functional teams, optimizes internal processes, and drives strategic initiatives to enhance operational efficiency and product effectiveness. This position plays a...

POSITION OVERVIEW : The VP of Compliance provides leadership and direction to ensure RCA operates in full compliance with applicable laws, regulations and internal policies. The role is responsible to foster a culture of ethics, integrity, accountability, and transparency while promoting best practices in clinical and operational settings. The VP of Compliance leads efforts to identify compliance risks across the organization, develops plans to monitor for ongoing adherence to legal and regulatory standards, and supports the development and implementation corrective action plans when necessary. The Vice President serves as the organization's Privacy Officer and oversees RCA's Compliance and Privacy and Security and Internal Audit Programs. The VP of Compliance provides oversight and guidance to all members of the Compliance Department and provides guidance to all Departments and service lines within the organization. The Vice President of Compliance also works closely with...